This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has major subject area list
|
Angiogenesis Inhibitors; Antibodies, Monoclonal; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Quinazolines
|
|
information resource reference
|
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia. Gynecol Oncol. 2008 Jul; 110(1):49-55.
|
|
label
|
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
|